Global Transfection Technologies

Transfection Technologies Comprehensive Study by Type (Lipofection, Electroporation, Nucleofection, Others), Application (Research Centers & Academic/Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others), Technology (Physical Based, Biochemical Based, Viral Based), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2032

Transfection Technologies Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Transfection Technologies Market Scope
Transfection is an approach to provide exogenous nucleic acids like DNA, RNA, or oligonucleotide into cells. Such nucleic acids will be transferred by chemical compounds or lipid transfection reagents that promote cellular absorption. This methodology is widely used for genomic studies (cell illustration, testing, RNA interference, in vitro research) however will be conducted for bio-production (vaccine and protein manufacturing) or healthful reasons (animal cell treatment). Nucleic acid delivery to cells will be accomplished by distinct physical techniques, like electroporation, sonoporation, or microinjection; but these procedures are relatively unsafe to cells. Transfection with chemical substances may be a better choice for maintaining healthy cell feasibility.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)
Key Companies ProfiledThermo Fisher Scientific (USA), Lonza Group (Switzerland), Merck KGaA (Sigma-Aldrich) (Germany), Bio-Rad Laboratories (USA), Promega Corporation (USA), Polyplus-transfection SA (France), MaxCyte Inc. (USA), Mirus Bio LLC (USA), Altogen Biosystems (USA) and IBA Lifesciences (Germany)
CAGR%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Transfection Technologies market throughout the predicted period.

Thermo Fisher Scientific (USA), Lonza Group (Switzerland), Merck KGaA (Sigma-Aldrich) (Germany), Bio-Rad Laboratories (USA), Promega Corporation (USA), Polyplus-transfection SA (France), MaxCyte Inc. (USA), Mirus Bio LLC (USA), Altogen Biosystems (USA) and IBA Lifesciences (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Takara Bio Inc. (Japan), Horizon Discovery (a PerkinElmer company) (UK), Viromer (Lipocalyx GmbH) (Germany), Boca Scientific Inc. (USA) and OZ Biosciences (France).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Transfection Technologies market by Type , by Application (Research Centers & Academic/Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others) and Region with country level break-up.

On the basis of geography, the market of Transfection Technologies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2024.

Market Leaders and their expansionary development strategies
In May 2018, Altogen Biosystems released a new version of AltoFect, a second-generation transfection reagent for the hard-to-transfect cell lines to primary cell types. AltoFect transfection reagent appears to have up to 85 percent efficiency of transfection in difficult-to-transfect cells, like B-cells, T-cells, and primary cell cultures. This reagent allows scientists to solve difficulties and constraints linked to primary cells and difficult-to-transfect cell lines.
In December 2018, Polyplus-transfection SA declared the release of PEIpro-GMP, a transfection reagent for medical and industrial lentivirus and adeno-associated disease (AAV) tissue & DNA therapy. This reagent was launched to promote the medical stage and the commercialization stage of manufacturing.


Influencing Trend:
Rising Application of The Transfection Procedures by The Academic Researchers

Market Growth Drivers:
Rising Incidences of Cancer and Increasing Number of Obese and Overweight Population

Challenges:
Home Brew Reagents Restrict Sale of Commercial Kits

Restraints:
High Cost of The Transfection Technologies

Opportunities:
Increase in Research and Development in The Field of Cell-Based Therapies, Advances in The Cell Research and The Therapeutic Delivery and Massive Funds by Government and Private Players

Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Transfection Technologies, Venture Capitalists and Private Equity Firms and End-Use Industry

Report Objectives / Segmentation Covered

By Type
  • Lipofection
  • Electroporation
  • Nucleofection
  • Others
By Application
  • Research Centers & Academic/Government Institutes
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others
By Technology
  • Physical Based
  • Biochemical Based
  • Viral Based

By Distribution Channel
  • Online
  • Offline

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Incidences of Cancer
      • 3.2.2. Increasing Number of Obese and Overweight Population
    • 3.3. Market Challenges
      • 3.3.1. Home Brew Reagents Restrict Sale of Commercial Kits
    • 3.4. Market Trends
      • 3.4.1. Rising Application of The Transfection Procedures by The Academic Researchers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Transfection Technologies, by Type, Application, Technology, Distribution Channel and Region (value and price ) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global Transfection Technologies (Value)
      • 5.2.1. Global Transfection Technologies by: Type (Value)
        • 5.2.1.1. Lipofection
        • 5.2.1.2. Electroporation
        • 5.2.1.3. Nucleofection
        • 5.2.1.4. Others
      • 5.2.2. Global Transfection Technologies by: Application (Value)
        • 5.2.2.1. Research Centers & Academic/Government Institutes
        • 5.2.2.2. Hospitals & Clinics
        • 5.2.2.3. Pharmaceutical & Biotechnology Companies
        • 5.2.2.4. Others
      • 5.2.3. Global Transfection Technologies by: Technology (Value)
        • 5.2.3.1. Physical Based
        • 5.2.3.2. Biochemical Based
        • 5.2.3.3. Viral Based
      • 5.2.4. Global Transfection Technologies by: Distribution Channel (Value)
        • 5.2.4.1. Online
        • 5.2.4.2. Offline
      • 5.2.5. Global Transfection Technologies Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Transfection Technologies (Price)
      • 5.3.1. Global Transfection Technologies by: Type (Price)
  • 6. Transfection Technologies: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (USA)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Lonza Group (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck KGaA (Sigma-Aldrich) (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bio-Rad Laboratories (USA)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Promega Corporation (USA)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Polyplus-transfection SA (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. MaxCyte Inc. (USA)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Mirus Bio LLC (USA)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Altogen Biosystems (USA)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. IBA Lifesciences (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Transfection Technologies Sale, by Type, Application, Technology, Distribution Channel and Region (value and price ) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global Transfection Technologies (Value)
      • 7.2.1. Global Transfection Technologies by: Type (Value)
        • 7.2.1.1. Lipofection
        • 7.2.1.2. Electroporation
        • 7.2.1.3. Nucleofection
        • 7.2.1.4. Others
      • 7.2.2. Global Transfection Technologies by: Application (Value)
        • 7.2.2.1. Research Centers & Academic/Government Institutes
        • 7.2.2.2. Hospitals & Clinics
        • 7.2.2.3. Pharmaceutical & Biotechnology Companies
        • 7.2.2.4. Others
      • 7.2.3. Global Transfection Technologies by: Technology (Value)
        • 7.2.3.1. Physical Based
        • 7.2.3.2. Biochemical Based
        • 7.2.3.3. Viral Based
      • 7.2.4. Global Transfection Technologies by: Distribution Channel (Value)
        • 7.2.4.1. Online
        • 7.2.4.2. Offline
      • 7.2.5. Global Transfection Technologies Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Transfection Technologies (Price)
      • 7.3.1. Global Transfection Technologies by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Transfection Technologies: by Type(USD Million)
  • Table 2. Transfection Technologies Lipofection , by Region USD Million (2019-2024)
  • Table 3. Transfection Technologies Electroporation , by Region USD Million (2019-2024)
  • Table 4. Transfection Technologies Nucleofection , by Region USD Million (2019-2024)
  • Table 5. Transfection Technologies Others , by Region USD Million (2019-2024)
  • Table 6. Transfection Technologies: by Application(USD Million)
  • Table 7. Transfection Technologies Research Centers & Academic/Government Institutes , by Region USD Million (2019-2024)
  • Table 8. Transfection Technologies Hospitals & Clinics , by Region USD Million (2019-2024)
  • Table 9. Transfection Technologies Pharmaceutical & Biotechnology Companies , by Region USD Million (2019-2024)
  • Table 10. Transfection Technologies Others , by Region USD Million (2019-2024)
  • Table 11. Transfection Technologies: by Technology(USD Million)
  • Table 12. Transfection Technologies Physical Based , by Region USD Million (2019-2024)
  • Table 13. Transfection Technologies Biochemical Based , by Region USD Million (2019-2024)
  • Table 14. Transfection Technologies Viral Based , by Region USD Million (2019-2024)
  • Table 15. Transfection Technologies: by Distribution Channel(USD Million)
  • Table 16. Transfection Technologies Online , by Region USD Million (2019-2024)
  • Table 17. Transfection Technologies Offline , by Region USD Million (2019-2024)
  • Table 18. South America Transfection Technologies, by Country USD Million (2019-2024)
  • Table 19. South America Transfection Technologies, by Type USD Million (2019-2024)
  • Table 20. South America Transfection Technologies, by Application USD Million (2019-2024)
  • Table 21. South America Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 22. South America Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 23. Brazil Transfection Technologies, by Type USD Million (2019-2024)
  • Table 24. Brazil Transfection Technologies, by Application USD Million (2019-2024)
  • Table 25. Brazil Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 26. Brazil Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 27. Argentina Transfection Technologies, by Type USD Million (2019-2024)
  • Table 28. Argentina Transfection Technologies, by Application USD Million (2019-2024)
  • Table 29. Argentina Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 30. Argentina Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 31. Rest of South America Transfection Technologies, by Type USD Million (2019-2024)
  • Table 32. Rest of South America Transfection Technologies, by Application USD Million (2019-2024)
  • Table 33. Rest of South America Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 34. Rest of South America Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 35. Asia Pacific Transfection Technologies, by Country USD Million (2019-2024)
  • Table 36. Asia Pacific Transfection Technologies, by Type USD Million (2019-2024)
  • Table 37. Asia Pacific Transfection Technologies, by Application USD Million (2019-2024)
  • Table 38. Asia Pacific Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 39. Asia Pacific Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 40. China Transfection Technologies, by Type USD Million (2019-2024)
  • Table 41. China Transfection Technologies, by Application USD Million (2019-2024)
  • Table 42. China Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 43. China Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 44. Japan Transfection Technologies, by Type USD Million (2019-2024)
  • Table 45. Japan Transfection Technologies, by Application USD Million (2019-2024)
  • Table 46. Japan Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 47. Japan Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 48. India Transfection Technologies, by Type USD Million (2019-2024)
  • Table 49. India Transfection Technologies, by Application USD Million (2019-2024)
  • Table 50. India Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 51. India Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 52. South Korea Transfection Technologies, by Type USD Million (2019-2024)
  • Table 53. South Korea Transfection Technologies, by Application USD Million (2019-2024)
  • Table 54. South Korea Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 55. South Korea Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 56. Taiwan Transfection Technologies, by Type USD Million (2019-2024)
  • Table 57. Taiwan Transfection Technologies, by Application USD Million (2019-2024)
  • Table 58. Taiwan Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 59. Taiwan Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 60. Australia Transfection Technologies, by Type USD Million (2019-2024)
  • Table 61. Australia Transfection Technologies, by Application USD Million (2019-2024)
  • Table 62. Australia Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 63. Australia Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 64. Rest of Asia-Pacific Transfection Technologies, by Type USD Million (2019-2024)
  • Table 65. Rest of Asia-Pacific Transfection Technologies, by Application USD Million (2019-2024)
  • Table 66. Rest of Asia-Pacific Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 67. Rest of Asia-Pacific Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 68. Europe Transfection Technologies, by Country USD Million (2019-2024)
  • Table 69. Europe Transfection Technologies, by Type USD Million (2019-2024)
  • Table 70. Europe Transfection Technologies, by Application USD Million (2019-2024)
  • Table 71. Europe Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 72. Europe Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 73. Germany Transfection Technologies, by Type USD Million (2019-2024)
  • Table 74. Germany Transfection Technologies, by Application USD Million (2019-2024)
  • Table 75. Germany Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 76. Germany Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 77. France Transfection Technologies, by Type USD Million (2019-2024)
  • Table 78. France Transfection Technologies, by Application USD Million (2019-2024)
  • Table 79. France Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 80. France Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 81. Italy Transfection Technologies, by Type USD Million (2019-2024)
  • Table 82. Italy Transfection Technologies, by Application USD Million (2019-2024)
  • Table 83. Italy Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 84. Italy Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 85. United Kingdom Transfection Technologies, by Type USD Million (2019-2024)
  • Table 86. United Kingdom Transfection Technologies, by Application USD Million (2019-2024)
  • Table 87. United Kingdom Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 88. United Kingdom Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 89. Netherlands Transfection Technologies, by Type USD Million (2019-2024)
  • Table 90. Netherlands Transfection Technologies, by Application USD Million (2019-2024)
  • Table 91. Netherlands Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 92. Netherlands Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 93. Rest of Europe Transfection Technologies, by Type USD Million (2019-2024)
  • Table 94. Rest of Europe Transfection Technologies, by Application USD Million (2019-2024)
  • Table 95. Rest of Europe Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 96. Rest of Europe Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 97. MEA Transfection Technologies, by Country USD Million (2019-2024)
  • Table 98. MEA Transfection Technologies, by Type USD Million (2019-2024)
  • Table 99. MEA Transfection Technologies, by Application USD Million (2019-2024)
  • Table 100. MEA Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 101. MEA Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 102. Middle East Transfection Technologies, by Type USD Million (2019-2024)
  • Table 103. Middle East Transfection Technologies, by Application USD Million (2019-2024)
  • Table 104. Middle East Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 105. Middle East Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 106. Africa Transfection Technologies, by Type USD Million (2019-2024)
  • Table 107. Africa Transfection Technologies, by Application USD Million (2019-2024)
  • Table 108. Africa Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 109. Africa Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 110. North America Transfection Technologies, by Country USD Million (2019-2024)
  • Table 111. North America Transfection Technologies, by Type USD Million (2019-2024)
  • Table 112. North America Transfection Technologies, by Application USD Million (2019-2024)
  • Table 113. North America Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 114. North America Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 115. United States Transfection Technologies, by Type USD Million (2019-2024)
  • Table 116. United States Transfection Technologies, by Application USD Million (2019-2024)
  • Table 117. United States Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 118. United States Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 119. Canada Transfection Technologies, by Type USD Million (2019-2024)
  • Table 120. Canada Transfection Technologies, by Application USD Million (2019-2024)
  • Table 121. Canada Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 122. Canada Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 123. Mexico Transfection Technologies, by Type USD Million (2019-2024)
  • Table 124. Mexico Transfection Technologies, by Application USD Million (2019-2024)
  • Table 125. Mexico Transfection Technologies, by Technology USD Million (2019-2024)
  • Table 126. Mexico Transfection Technologies, by Distribution Channel USD Million (2019-2024)
  • Table 127. Transfection Technologies: by Type(USD/Units)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Transfection Technologies: by Type(USD Million)
  • Table 139. Transfection Technologies Lipofection , by Region USD Million (2027-2032)
  • Table 140. Transfection Technologies Electroporation , by Region USD Million (2027-2032)
  • Table 141. Transfection Technologies Nucleofection , by Region USD Million (2027-2032)
  • Table 142. Transfection Technologies Others , by Region USD Million (2027-2032)
  • Table 143. Transfection Technologies: by Application(USD Million)
  • Table 144. Transfection Technologies Research Centers & Academic/Government Institutes , by Region USD Million (2027-2032)
  • Table 145. Transfection Technologies Hospitals & Clinics , by Region USD Million (2027-2032)
  • Table 146. Transfection Technologies Pharmaceutical & Biotechnology Companies , by Region USD Million (2027-2032)
  • Table 147. Transfection Technologies Others , by Region USD Million (2027-2032)
  • Table 148. Transfection Technologies: by Technology(USD Million)
  • Table 149. Transfection Technologies Physical Based , by Region USD Million (2027-2032)
  • Table 150. Transfection Technologies Biochemical Based , by Region USD Million (2027-2032)
  • Table 151. Transfection Technologies Viral Based , by Region USD Million (2027-2032)
  • Table 152. Transfection Technologies: by Distribution Channel(USD Million)
  • Table 153. Transfection Technologies Online , by Region USD Million (2027-2032)
  • Table 154. Transfection Technologies Offline , by Region USD Million (2027-2032)
  • Table 155. South America Transfection Technologies, by Country USD Million (2027-2032)
  • Table 156. South America Transfection Technologies, by Type USD Million (2027-2032)
  • Table 157. South America Transfection Technologies, by Application USD Million (2027-2032)
  • Table 158. South America Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 159. South America Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 160. Brazil Transfection Technologies, by Type USD Million (2027-2032)
  • Table 161. Brazil Transfection Technologies, by Application USD Million (2027-2032)
  • Table 162. Brazil Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 163. Brazil Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 164. Argentina Transfection Technologies, by Type USD Million (2027-2032)
  • Table 165. Argentina Transfection Technologies, by Application USD Million (2027-2032)
  • Table 166. Argentina Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 167. Argentina Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 168. Rest of South America Transfection Technologies, by Type USD Million (2027-2032)
  • Table 169. Rest of South America Transfection Technologies, by Application USD Million (2027-2032)
  • Table 170. Rest of South America Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 171. Rest of South America Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 172. Asia Pacific Transfection Technologies, by Country USD Million (2027-2032)
  • Table 173. Asia Pacific Transfection Technologies, by Type USD Million (2027-2032)
  • Table 174. Asia Pacific Transfection Technologies, by Application USD Million (2027-2032)
  • Table 175. Asia Pacific Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 176. Asia Pacific Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 177. China Transfection Technologies, by Type USD Million (2027-2032)
  • Table 178. China Transfection Technologies, by Application USD Million (2027-2032)
  • Table 179. China Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 180. China Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 181. Japan Transfection Technologies, by Type USD Million (2027-2032)
  • Table 182. Japan Transfection Technologies, by Application USD Million (2027-2032)
  • Table 183. Japan Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 184. Japan Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 185. India Transfection Technologies, by Type USD Million (2027-2032)
  • Table 186. India Transfection Technologies, by Application USD Million (2027-2032)
  • Table 187. India Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 188. India Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 189. South Korea Transfection Technologies, by Type USD Million (2027-2032)
  • Table 190. South Korea Transfection Technologies, by Application USD Million (2027-2032)
  • Table 191. South Korea Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 192. South Korea Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 193. Taiwan Transfection Technologies, by Type USD Million (2027-2032)
  • Table 194. Taiwan Transfection Technologies, by Application USD Million (2027-2032)
  • Table 195. Taiwan Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 196. Taiwan Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 197. Australia Transfection Technologies, by Type USD Million (2027-2032)
  • Table 198. Australia Transfection Technologies, by Application USD Million (2027-2032)
  • Table 199. Australia Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 200. Australia Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 201. Rest of Asia-Pacific Transfection Technologies, by Type USD Million (2027-2032)
  • Table 202. Rest of Asia-Pacific Transfection Technologies, by Application USD Million (2027-2032)
  • Table 203. Rest of Asia-Pacific Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 204. Rest of Asia-Pacific Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 205. Europe Transfection Technologies, by Country USD Million (2027-2032)
  • Table 206. Europe Transfection Technologies, by Type USD Million (2027-2032)
  • Table 207. Europe Transfection Technologies, by Application USD Million (2027-2032)
  • Table 208. Europe Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 209. Europe Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 210. Germany Transfection Technologies, by Type USD Million (2027-2032)
  • Table 211. Germany Transfection Technologies, by Application USD Million (2027-2032)
  • Table 212. Germany Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 213. Germany Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 214. France Transfection Technologies, by Type USD Million (2027-2032)
  • Table 215. France Transfection Technologies, by Application USD Million (2027-2032)
  • Table 216. France Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 217. France Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 218. Italy Transfection Technologies, by Type USD Million (2027-2032)
  • Table 219. Italy Transfection Technologies, by Application USD Million (2027-2032)
  • Table 220. Italy Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 221. Italy Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 222. United Kingdom Transfection Technologies, by Type USD Million (2027-2032)
  • Table 223. United Kingdom Transfection Technologies, by Application USD Million (2027-2032)
  • Table 224. United Kingdom Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 225. United Kingdom Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 226. Netherlands Transfection Technologies, by Type USD Million (2027-2032)
  • Table 227. Netherlands Transfection Technologies, by Application USD Million (2027-2032)
  • Table 228. Netherlands Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 229. Netherlands Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 230. Rest of Europe Transfection Technologies, by Type USD Million (2027-2032)
  • Table 231. Rest of Europe Transfection Technologies, by Application USD Million (2027-2032)
  • Table 232. Rest of Europe Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 233. Rest of Europe Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 234. MEA Transfection Technologies, by Country USD Million (2027-2032)
  • Table 235. MEA Transfection Technologies, by Type USD Million (2027-2032)
  • Table 236. MEA Transfection Technologies, by Application USD Million (2027-2032)
  • Table 237. MEA Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 238. MEA Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 239. Middle East Transfection Technologies, by Type USD Million (2027-2032)
  • Table 240. Middle East Transfection Technologies, by Application USD Million (2027-2032)
  • Table 241. Middle East Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 242. Middle East Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 243. Africa Transfection Technologies, by Type USD Million (2027-2032)
  • Table 244. Africa Transfection Technologies, by Application USD Million (2027-2032)
  • Table 245. Africa Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 246. Africa Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 247. North America Transfection Technologies, by Country USD Million (2027-2032)
  • Table 248. North America Transfection Technologies, by Type USD Million (2027-2032)
  • Table 249. North America Transfection Technologies, by Application USD Million (2027-2032)
  • Table 250. North America Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 251. North America Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 252. United States Transfection Technologies, by Type USD Million (2027-2032)
  • Table 253. United States Transfection Technologies, by Application USD Million (2027-2032)
  • Table 254. United States Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 255. United States Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 256. Canada Transfection Technologies, by Type USD Million (2027-2032)
  • Table 257. Canada Transfection Technologies, by Application USD Million (2027-2032)
  • Table 258. Canada Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 259. Canada Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 260. Mexico Transfection Technologies, by Type USD Million (2027-2032)
  • Table 261. Mexico Transfection Technologies, by Application USD Million (2027-2032)
  • Table 262. Mexico Transfection Technologies, by Technology USD Million (2027-2032)
  • Table 263. Mexico Transfection Technologies, by Distribution Channel USD Million (2027-2032)
  • Table 264. Transfection Technologies: by Type(USD/Units)
  • Table 265. Research Programs/Design for This Report
  • Table 266. Key Data Information from Secondary Sources
  • Table 267. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Transfection Technologies: by Type USD Million (2019-2024)
  • Figure 5. Global Transfection Technologies: by Application USD Million (2019-2024)
  • Figure 6. Global Transfection Technologies: by Technology USD Million (2019-2024)
  • Figure 7. Global Transfection Technologies: by Distribution Channel USD Million (2019-2024)
  • Figure 8. South America Transfection Technologies Share (%), by Country
  • Figure 9. Asia Pacific Transfection Technologies Share (%), by Country
  • Figure 10. Europe Transfection Technologies Share (%), by Country
  • Figure 11. MEA Transfection Technologies Share (%), by Country
  • Figure 12. North America Transfection Technologies Share (%), by Country
  • Figure 13. Global Transfection Technologies: by Type USD/Units (2019-2024)
  • Figure 14. Global Transfection Technologies share by Players 2024 (%)
  • Figure 15. Global Transfection Technologies share by Players (Top 3) 2024(%)
  • Figure 16. Global Transfection Technologies share by Players (Top 5) 2024(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Thermo Fisher Scientific (USA) Revenue, Net Income and Gross profit
  • Figure 19. Thermo Fisher Scientific (USA) Revenue: by Geography 2024
  • Figure 20. Lonza Group (Switzerland) Revenue, Net Income and Gross profit
  • Figure 21. Lonza Group (Switzerland) Revenue: by Geography 2024
  • Figure 22. Merck KGaA (Sigma-Aldrich) (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Merck KGaA (Sigma-Aldrich) (Germany) Revenue: by Geography 2024
  • Figure 24. Bio-Rad Laboratories (USA) Revenue, Net Income and Gross profit
  • Figure 25. Bio-Rad Laboratories (USA) Revenue: by Geography 2024
  • Figure 26. Promega Corporation (USA) Revenue, Net Income and Gross profit
  • Figure 27. Promega Corporation (USA) Revenue: by Geography 2024
  • Figure 28. Polyplus-transfection SA (France) Revenue, Net Income and Gross profit
  • Figure 29. Polyplus-transfection SA (France) Revenue: by Geography 2024
  • Figure 30. MaxCyte Inc. (USA) Revenue, Net Income and Gross profit
  • Figure 31. MaxCyte Inc. (USA) Revenue: by Geography 2024
  • Figure 32. Mirus Bio LLC (USA) Revenue, Net Income and Gross profit
  • Figure 33. Mirus Bio LLC (USA) Revenue: by Geography 2024
  • Figure 34. Altogen Biosystems (USA) Revenue, Net Income and Gross profit
  • Figure 35. Altogen Biosystems (USA) Revenue: by Geography 2024
  • Figure 36. IBA Lifesciences (Germany) Revenue, Net Income and Gross profit
  • Figure 37. IBA Lifesciences (Germany) Revenue: by Geography 2024
  • Figure 38. Global Transfection Technologies: by Type USD Million (2027-2032)
  • Figure 39. Global Transfection Technologies: by Application USD Million (2027-2032)
  • Figure 40. Global Transfection Technologies: by Technology USD Million (2027-2032)
  • Figure 41. Global Transfection Technologies: by Distribution Channel USD Million (2027-2032)
  • Figure 42. South America Transfection Technologies Share (%), by Country
  • Figure 43. Asia Pacific Transfection Technologies Share (%), by Country
  • Figure 44. Europe Transfection Technologies Share (%), by Country
  • Figure 45. MEA Transfection Technologies Share (%), by Country
  • Figure 46. North America Transfection Technologies Share (%), by Country
  • Figure 47. Global Transfection Technologies: by Type USD/Units (2027-2032)
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (USA)
  • Lonza Group (Switzerland)
  • Merck KGaA (Sigma-Aldrich) (Germany)
  • Bio-Rad Laboratories (USA)
  • Promega Corporation (USA)
  • Polyplus-transfection SA (France)
  • MaxCyte Inc. (USA)
  • Mirus Bio LLC (USA)
  • Altogen Biosystems (USA)
  • IBA Lifesciences (Germany)
Additional players considered in the study are as follows:
Takara Bio Inc. (Japan) , Horizon Discovery (a PerkinElmer company) (UK) , Viromer (Lipocalyx GmbH) (Germany) , Boca Scientific Inc. (USA) , OZ Biosciences (France)
Select User Access Type

Key Highlights of Report


Feb 2025 214 Pages 96 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Transfection Technologies Quantitative research analysis
Global Transfection Technologies Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Transfection Technologies Market are by type [Lipofection, Electroporation, Nucleofection and Others], by end use application [Research Centers & Academic/Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others].
The Transfection Technologies Market is gaining popularity and expected to see strong valuation by 2032.
  • Rising Incidences of Cancer
  • Increasing Number of Obese and Overweight Population

Know More About Global Transfection Technologies Report?

Have a Query? Click Here

Other Related Reports

Medical Billing Software Comprehensive Study by Type (Claims Scrubbing, Code & Charge Entry, Compliance Tracking), Application (Hospitals, Clinics, Other), Pricing Option (One-Time, Annual, Monthly, ...
$ 3250
Educational Robotic Comprehensive Study by Type (Type I, Type II), Application (Reconfigurable robots, Wheeled robots, Humanoid robots), Component (Software, Hardware, Sensor, Control System, Actuato...
$ 3450
Smart Fitness Comprehensive Study by Distribution Channels (Online Sales Channels {E-Commerce, Company Website}, Offline Sales Channels {Hypermarket, Brand Outlet, Retail Store}), Device (SmartWatch...
$ 3500
3D Printing in Electronics Comprehensive Study by Type (3d printers, Materials, Services), Application (Consumer electronics, Automotive, Aerospace, Industrial, Others) Players and Region - Global Ma...
$ 3500
Robotics System Integration Comprehensive Study by Type (Building Management System (BMS), Cloud Integration, Integrated Communication, Data Center Infrastructure Management (DCIM), Network Integrati...
$ 3750
4G Devices Comprehensive Study by Type (Smartphones, Tablets), Application (Communication, Entertainment), Distribution Channel (Multi-brand Store, Single Brand Store, Others) Players and Region - Gl...
$ 3500